» Articles » PMID: 32225036

An Updated Overview on Nanonutraceuticals: Focus on Nanoprebiotics and Nanoprobiotics

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Apr 1
PMID 32225036
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Over the last few years, the application of nanotechnology to nutraceuticals has been rapidly growing due to its ability to enhance the bioavailability of the loaded active ingredients, resulting in improved therapeutic/nutraceutical outcomes. The focus of this work is nanoprebiotics and nanoprobiotics, terms which stand for the loading of a set of compounds (e.g., prebiotics, probiotics, and synbiotics) in nanoparticles that work as absorption enhancers in the gastrointestinal tract. In this manuscript, the main features of prebiotics and probiotics are highlighted, together with the discussion of emerging applications of nanotechnologies in their formulation. Current research strategies are also discussed, in particular the promising use of nanofibers for the delivery of probiotics. Synbiotic-based nanoparticles represent an innovative trend within this area of interest. As only few experimental studies on nanoprebiotics and nanoprobiotics are available in the scientific literature, research on this prominent field is needed, covering effectiveness, bioavailability, and safety aspects.

Citing Articles

Advances in kidney disease: pathogenesis and therapeutic targets.

Boima V, Agyekum A, Ganatra K, Agyekum F, Kwakyi E, Inusah J Front Med (Lausanne). 2025; 12:1526090.

PMID: 40027896 PMC: 11868101. DOI: 10.3389/fmed.2025.1526090.


Formation Mechanisms of Protein Coronas on Food-Related Nanoparticles: Their Impact on Digestive System and Bioactive Compound Delivery.

Rui X, Fu K, Wang H, Pan T, Wang W Foods. 2025; 14(3).

PMID: 39942105 PMC: 11817056. DOI: 10.3390/foods14030512.


Biopolymer encapsulation for improved probiotic delivery: Advancements and challenges.

Vijayaram S, Sinha R, Faggio C, Ringo E, Chou C AIMS Microbiol. 2024; 10(4):986-1023.

PMID: 39628726 PMC: 11609427. DOI: 10.3934/microbiol.2024043.


Microscopic messengers: microbiota-derived bacterial extracellular vesicles in inflammatory bowel disease.

Zubair M, Abouelnazar F, Dawood A, Pan J, Zheng X, Chen T Front Microbiol. 2024; 15:1481496.

PMID: 39606115 PMC: 11600980. DOI: 10.3389/fmicb.2024.1481496.


Antioxidant, Anti-Inflammatory, Anti-Diabetic, and Pro-Osteogenic Activities of Polyphenols for the Treatment of Two Different Chronic Diseases: Type 2 Diabetes Mellitus and Osteoporosis.

Scarpa E, Antonelli A, Balercia G, Sabatelli S, Maggi F, Caprioli G Biomolecules. 2024; 14(7).

PMID: 39062550 PMC: 11275061. DOI: 10.3390/biom14070836.


References
1.
de Jong W, Borm P . Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine. 2008; 3(2):133-49. PMC: 2527668. DOI: 10.2147/ijn.s596. View

2.
Choi W, Dong H, Jeong H, Jung H, Kim Y, Kim T . Antiobesity Effects of LMT1-48 Accompanied by Inhibition of in the Intestine of Diet-Induced Obese Mice. J Med Food. 2019; 22(6):560-566. DOI: 10.1089/jmf.2018.4329. View

3.
Jeevanandam J, Barhoum A, Chan Y, Dufresne A, Danquah M . Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol. 2018; 9:1050-1074. PMC: 5905289. DOI: 10.3762/bjnano.9.98. View

4.
Lin P, Li S, Lin H, Shih C . Germinated brown rice combined with and subsp. inhibits colorectal carcinogenesis in rats. Food Sci Nutr. 2019; 7(1):216-224. PMC: 6341155. DOI: 10.1002/fsn3.864. View

5.
Severino P, Souto E, Pinho S, Santana M . Hydrophilic coating of mitotane-loaded lipid nanoparticles: preliminary studies for mucosal adhesion. Pharm Dev Technol. 2011; 18(3):577-81. DOI: 10.3109/10837450.2011.614250. View